Cargando…
Interaction of hallucinogenic rapid-acting antidepressants with mGlu2/3 receptor ligands as a window for more effective therapies
The desire to find a gold-standard therapy for depression is still ongoing. Developing one universal and effective pharmacotherapy remains troublesome due to the high complexity and variety of symptoms. Over the last decades, the understanding of the mechanism of pathophysiology of depression and it...
Autores principales: | Chruścicka-Smaga, Barbara, Machaczka, Agata, Szewczyk, Bernadeta, Pilc, Andrzej |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10660980/ https://www.ncbi.nlm.nih.gov/pubmed/37932583 http://dx.doi.org/10.1007/s43440-023-00547-4 |
Ejemplares similares
-
The functional cooperation of 5-HT(1A) and mGlu4R in HEK-293 cell line
por: Burnat, Grzegorz, et al.
Publicado: (2020) -
On the mechanism of the antidepressant-like action of group II mGlu receptor antagonist, MGS0039
por: Pałucha-Poniewiera, Agnieszka, et al.
Publicado: (2010) -
Group II mGlu receptor antagonist LY341495 enhances the antidepressant-like effects of ketamine in the forced swim test in rats
por: Podkowa, Karolina, et al.
Publicado: (2016) -
Structural insights into dimerization and activation of the mGlu2–mGlu3 and mGlu2–mGlu4 heterodimers
por: Wang, Xinwei, et al.
Publicado: (2023) -
New 1,2,4-oxadiazole derivatives with positive mGlu(4) receptor modulation activity and antipsychotic-like properties
por: Stankiewicz, Anna, et al.
Publicado: (2021)